There may be new treatment available soon for those with multiple sclerosis (MS), according to results released by the University of California, San Francisco-led trail of Ofatumumab. This is a drug that alters the immune system, typically over the course of a year and a half.

More than 900 volunteers with MS were given shots of Ofatumumab and within the first year of treatment they had fewer flare-ups and their blood work showed encouraging results. In the second year, patients found no symptoms for 90% of them.
The company is currently waiting for approval from the FDA. Read more about the promising findings and the ways that it may transform the lives of those with MS.